Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

accord healthcare s.l.u. - acetat de abirateron - prostate neoplasme - terapia endocrină - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

mylan ireland limited - acetat de abirateron - prostate neoplasme - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

krka, d.d., novo mesto - acetat de abirateron - prostate neoplasme - terapia endocrină - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

accord healthcare s.l.u. - leuprorelin mesilate - prostate neoplasme - terapia endocrină - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.

Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

advanced accelerator applications (italy) s.r.l. - italia - gallium (68ga) gozetotida - trusa (kit) pt. preparate radiofarmaceutice - 25micrograme - preparate pentru detectarea tumorilor alte radiofarmaceutice pt. detectarea tumorilor

Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

lilly s. a. - tadalafilum - comprimate filmate - 20 mg

Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

ipsen pharma - macrogolum - pulbere pentru solutie orala

Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

pharmaceutical works polpharma s.a. - acid acetylsalicylicum - comprimate efervescente - 330 mg

Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zdorovie srl, companie farmaceutica - lidocaini hydrochloridum - solutie injectabila - 10%

Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

zdorovie srl, companie farmaceutica - lidocaini hydrochloridum - solutie injectabila - 2%